Literature DB >> 26745432

Action Potential Shape Is a Crucial Measure of Cell Type of Stem Cell-Derived Cardiocytes.

Glenna C L Bett1, Aaron D Kaplan2, Randall L Rasmusson3.   

Abstract

Mesh:

Year:  2016        PMID: 26745432      PMCID: PMC4805866          DOI: 10.1016/j.bpj.2015.11.026

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


× No keyword cloud information.
  28 in total

1.  Rigorous Phenotyping of Cardiac iPSC Preparations Requires Knowledge of Their Resting Potential(s).

Authors:  Wayne R Giles; Denis Noble
Journal:  Biophys J       Date:  2016-01-05       Impact factor: 4.033

2.  Generation of induced pluripotent stem cell lines from Friedreich ataxia patients.

Authors:  Jun Liu; Paul J Verma; Marguerite V Evans-Galea; Martin B Delatycki; Anna Michalska; Jessie Leung; Duncan Crombie; Joseph P Sarsero; Robert Williamson; Mirella Dottori; Alice Pébay
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

3.  Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells.

Authors:  Jong J Kim; Lei Yang; Bo Lin; Xiaodong Zhu; Bin Sun; Aaron D Kaplan; Glenna C L Bett; Randall L Rasmusson; Barry London; Guy Salama
Journal:  J Mol Cell Cardiol       Date:  2015-01-30       Impact factor: 5.000

4.  Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts.

Authors:  Hui Gai; Elaine Lai-Han Leung; Peter D Costantino; Jerell R Aguila; David M Nguyen; Louis M Fink; David C Ward; Yupo Ma
Journal:  Cell Biol Int       Date:  2009-09-01       Impact factor: 3.612

Review 5.  Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models.

Authors:  Udo Kraushaar; Thomas Meyer; Dietmar Hess; Lior Gepstein; Christine L Mummery; Stefan R Braam; Elke Guenther
Journal:  Expert Opin Drug Saf       Date:  2011-11-22       Impact factor: 4.250

6.  Relaxin suppresses atrial fibrillation by reversing fibrosis and myocyte hypertrophy and increasing conduction velocity and sodium current in spontaneously hypertensive rat hearts.

Authors:  Ashish Parikh; Divyang Patel; Charles F McTiernan; Wenyu Xiang; Jamie Haney; Lei Yang; Bo Lin; Aaron D Kaplan; Glenna C L Bett; Randall L Rasmusson; Sanjeev G Shroff; David Schwartzman; Guy Salama
Journal:  Circ Res       Date:  2013-06-07       Impact factor: 17.367

7.  Regional variation of the inwardly rectifying potassium current in the canine heart and the contributions to differences in action potential repolarization.

Authors:  Jonathan M Cordeiro; Tanya Zeina; Robert Goodrow; Aaron D Kaplan; Lini M Thomas; Vladislav V Nesterenko; Jacqueline A Treat; Leo Hawel; Craig Byus; Glenna C Bett; Randall L Rasmusson; Brian K Panama
Journal:  J Mol Cell Cardiol       Date:  2015-04-15       Impact factor: 5.000

8.  Modelling the long QT syndrome with induced pluripotent stem cells.

Authors:  Ilanit Itzhaki; Leonid Maizels; Irit Huber; Limor Zwi-Dantsis; Oren Caspi; Aaron Winterstern; Oren Feldman; Amira Gepstein; Gil Arbel; Haim Hammerman; Monther Boulos; Lior Gepstein
Journal:  Nature       Date:  2011-01-16       Impact factor: 49.962

9.  Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.

Authors:  Yumiko Nozaki; Yayoi Honda; Shinji Tsujimoto; Hitoshi Watanabe; Takeshi Kunimatsu; Hitoshi Funabashi
Journal:  Toxicol Appl Pharmacol       Date:  2014-04-15       Impact factor: 4.219

Review 10.  Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia research.

Authors:  Daniel Sinnecker; Alexander Goedel; Karl-Ludwig Laugwitz; Alessandra Moretti
Journal:  Circ Res       Date:  2013-03-15       Impact factor: 17.367

View more
  1 in total

Review 1.  Human iPSC-Derived Cardiomyocytes for Investigation of Disease Mechanisms and Therapeutic Strategies in Inherited Arrhythmia Syndromes: Strengths and Limitations.

Authors:  Simona Casini; Arie O Verkerk; Carol Ann Remme
Journal:  Cardiovasc Drugs Ther       Date:  2017-06       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.